Janney Montgomery Scott
CRBU icon

Janney Montgomery Scott’s Caribou Biosciences CRBU Stock Holding History

Janney Montgomery Scott’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,793
Closed -$107K – 2511
2022
Q2 		$107K Buy
+18,793
New +$144K ﹤0.01% 2233

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Janney Montgomery Scott's CRBU Position: Q3 2022 in Review

Janney Montgomery Scott sold out of Caribou Biosciences (CRBU) in Q3 2022, closing a stake of 18,793 shares — an estimated $107K sold.

Janney Montgomery Scott first reported a position in CRBU in Q2 2022 and held it in 1 quarter. The position peaked at $107K in Q2 2022. 113 funds tracked by Wall St. Rank hold CRBU as of Q3 2022.

  • Janney Montgomery Scott reported no remaining Caribou Biosciences position as of Q3 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 18,793 Caribou Biosciences shares in Q3 2022, an estimated $107K.
  • Janney Montgomery Scott first reported a position in Caribou Biosciences in Q2 2022 and held it in 1 quarter.
  • Janney Montgomery Scott's Caribou Biosciences position peaked at $107K in Q2 2022.
  • 113 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2022.

Based on Janney Montgomery Scott's 13F filing for Q3 2022, filed 25 Oct 2022.